Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Rein Therapeutics (RNTX) Shares Outstanding (2016 - 2025)

Rein Therapeutics filings provide 10 years of Shares Outstanding readings, the most recent being $27.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 27.16% year-over-year to $27.6 million, compared with a TTM value of $27.6 million through Dec 2025, up 27.16%, and an annual FY2025 reading of $27.6 million, up 27.16% over the prior year.
  • Shares Outstanding hit $27.6 million in Q4 2025 for Rein Therapeutics, up from $25.1 million in the prior quarter.
  • The five-year high for Shares Outstanding was $90.6 million in Q3 2021, with the low at $4.5 million in Q4 2021.
  • Median Shares Outstanding over the past 5 years was $19.2 million (2024), compared with a mean of $24.6 million.
  • The sharpest move saw Shares Outstanding plummeted 94.99% in 2022, then surged 377.1% in 2024.
  • Year by year, Shares Outstanding stood at $4.5 million in 2021, then rose by 0.28% to $4.5 million in 2022, then rose by 7.58% to $4.9 million in 2023, then skyrocketed by 343.47% to $21.7 million in 2024, then rose by 27.16% to $27.6 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $27.6 million, $25.1 million, and $23.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.